TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7740062

Group type: EXPERIMENTAL
Intervention: ultralow tar/nicotine (tn) cigarettes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TN and tn cigarettes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TN, tn, and Tn cigarettes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Blocking of olfactory cues
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: tn cigarettes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Tn cigarettes
Number of subjects: 12
Study: 1705193

Group type: EXPERIMENTAL
Intervention: Combined contraceptive pills containing desogestrel and gestodene
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control values (not specified)
Number of subjects: 40
Study: 6789354

Group type: EXPERIMENTAL
Intervention: Flurazepam 15 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Flurazepam 26 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Flurazepam 45 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Flurazepam (all doses)
Number of subjects: 24
Study: 31844458

Group type: EXPERIMENTAL
Intervention: Online course on antimicrobial resistance (AMR)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group online course about microorganisms in dentistry
Number of subjects: 64
Study: 28714526

Group type: EXPERIMENTAL
Intervention: Postconditioning 4 cycles of 30 s inflation and 30 s deflation (PC-1)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Postconditioning 4 cycles of 60 s (PC-2)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Postconditioning (PC-1 and PC-2 combined)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 25622803

Group type: EXPERIMENTAL
Intervention: Short implants placed with osteotome sinus floor elevation (OSFE) without grafting (test group)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Short implants placed with osteotome sinus floor elevation (OSFE) with grafting (control group)
Number of subjects: 37
Study: 23265387

Group type: EXPERIMENTAL
Intervention: Screening arm (15D)
Number of subjects: 7011

Group type: COMPARATOR
Intervention: Control arm (15D)
Number of subjects: 7011

Group type: EXPERIMENTAL
Intervention: Screening arm (EQ-5D)
Number of subjects: 7011

Group type: COMPARATOR
Intervention: Control arm (EQ-5D)
Number of subjects: 7011

Group type: EXPERIMENTAL
Intervention: Screening arm (SF-6D)
Number of subjects: 7011

Group type: COMPARATOR
Intervention: Control arm (SF-6D)
Number of subjects: 7011

Group type: EXPERIMENTAL
Intervention: Screening arm (15D, subsample)
Number of subjects: 7011

Group type: COMPARATOR
Intervention: Control arm (15D, subsample)
Number of subjects: 7011

Group type: EXPERIMENTAL
Intervention: Screening arm (EQ-5D, subsample)
Number of subjects: 7011

Group type: COMPARATOR
Intervention: Control arm (EQ-5D, subsample)
Number of subjects: 7011

Group type: EXPERIMENTAL
Intervention: Screening arm (SF-6D, subsample)
Number of subjects: 7011

Group type: COMPARATOR
Intervention: Control arm (SF-6D, subsample)
Number of subjects: 7011
Study: 21958927

Group type: EXPERIMENTAL
Intervention: air-Q LMA
Number of subjects: 24

Group type: COMPARATOR
Intervention: Soft Seal LMA
Number of subjects: 24
Study: 20390483

Group type: EXPERIMENTAL
Intervention: Exclusive gay
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Gay with some bisexuality
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Gay with mixed sexual history
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Bisexual
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Heterosexual with male-to-male sex
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Demographic and social characteristics
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Sexual activity and partnerships
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Experience of discrimination and PLWHA activities
Number of subjects: 2932
Study: 17634459

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol 400 mg every 4 weeks through week 24
Number of subjects: 668

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 668
Study: 15618252

Group type: EXPERIMENTAL
Intervention: 30 microg rLH
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: 60 microg rLH
Number of subjects: 153
Study: 11973100

Group type: EXPERIMENTAL
Intervention: Carticaine 4% adrenaline hyaluronidase mixture
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lidocaine 2% adrenaline hyaluronidase mixture
Number of subjects: 200
Study: 9787958

Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 16

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 16
Study: 7543701

Group type: EXPERIMENTAL
Intervention: Paclitaxel (Taxol)
Number of subjects: 0
Study: 2774785

Group type: EXPERIMENTAL
Intervention: Physician audit with periodic feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visit‐based strategy directed at both patient and physician
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control arm)
Number of subjects: 0
Study: 215096

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine (120 mg doses)
Number of subjects: 0
Study: 31077671

Group type: EXPERIMENTAL
Intervention: Ketoprofen patch
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac patch
Number of subjects: 40
Study: 28975998

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 16
Study: 26341987

Group type: EXPERIMENTAL
Intervention: AZD5069 80 mg orally twice daily for 28 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 23561868

Group type: EXPERIMENTAL
Intervention: Pilates exercise program (twice a week for one year)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Home exercise program (thoracic extension exercises)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison between Pilates and home exercise groups
Number of subjects: 70
Study: 22169631

Group type: EXPERIMENTAL
Intervention: Tailored Internet-based intervention for smoking cessation
Number of subjects: 2298

Group type: COMPARATOR
Intervention: Nontailored Internet-based intervention for smoking cessation (Control)
Number of subjects: 2298
Study: 19209172

Group type: EXPERIMENTAL
Intervention: Decision aid intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 111
Study: 16719722

Group type: EXPERIMENTAL
Intervention: Experimental condition (viewed 3 ads challenging normative beliefs about marijuana use)
Number of subjects: 435

Group type: COMPARATOR
Intervention: Control condition (not explicitly mentioned in the abstract)
Number of subjects: 435
Study: 14734920

Group type: EXPERIMENTAL
Intervention: Injection rate of 0.5 mL/s
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Injection volume (2, 10, 20 mL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flow rates of 1 to 2 mL/s with a minimum of 20 mL gadolinium dimeglumine
Number of subjects: 60
Study: 11743482

Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gluconate/61% ethanol antiseptic hand preparation
Number of subjects: 58

Group type: COMPARATOR
Intervention: 4% chlorhexidine gluconate antimicrobial product (control)
Number of subjects: 58
Study: 10638893

Group type: EXPERIMENTAL
Intervention: Morphine (0.2 mg/kg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fentanyl (2 microg/kg)
Number of subjects: 30
Study: 9162612

Group type: EXPERIMENTAL
Intervention: Guar gum bread (7.6 g guar per meal)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (75 g carbohydrate breakfast meals of control bread)
Number of subjects: 14
Study: 1513939

Group type: EXPERIMENTAL
Intervention: Intradural anesthesia with 26G needle, puncture directed parallel to dura mater fibers (group 1)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Intradural anesthesia with 26G needle, puncture directed perpendicular to dura mater fibers (group 2)
Number of subjects: 270
Study: 6839561

Group type: EXPERIMENTAL
Intervention: Tizolemide (50 mg i.v.)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tizolemide
Number of subjects: 15
Study: 31347916

Group type: EXPERIMENTAL
Intervention: Knowledge/tools and solutions for improving experimental design
Number of subjects: 16
Study: 30120138

Group type: EXPERIMENTAL
Intervention: Fremanezumab 225 mg
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Fremanezumab 675 mg
Number of subjects: 570

Group type: EXPERIMENTAL
Intervention: Fremanezumab 900 mg
Number of subjects: 570

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 570
Study: 27614276

Group type: EXPERIMENTAL
Intervention: Equestrian therapy (24 biweekly sessions over 3 months)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study: 24132052

Group type: EXPERIMENTAL
Intervention: Methadone maintenance therapy (MMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 22192423

Group type: EXPERIMENTAL
Intervention: Split-dose picosulfate, magnesium oxide, and citric acid solution (1 sachet at 7:00 pm and another sachet 4 hours before colonoscopy)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Traditional dosing regimen (1 sachet at 5:00 pm and 10:00 pm the night before colonoscopy)
Number of subjects: 236
Study: 21056283

Group type: EXPERIMENTAL
Intervention: Dairy-free diet for 2 weeks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Baseline d-IBS patients
Number of subjects: 13
Study: 17592349

Group type: EXPERIMENTAL
Intervention: Thiopentone 3 mg/kg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Thiopentone 5 mg/kg
Number of subjects: 41
Study: 16298774

Group type: EXPERIMENTAL
Intervention: Lavender oil
Number of subjects: 31

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 31
Study: 12467851

Group type: EXPERIMENTAL
Intervention: Parametric method of estimating Doppler ultrasound umbilical maximal flow waveform envelope; No specific dosage or duration mentioned.
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Modification of the estimation procedure; No specific dosage or duration mentioned.
Number of subjects: 327
Study: 9822227

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 91
Study: 7644550

Group type: EXPERIMENTAL
Intervention: Circular array of six coloured circles (condition i)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Equiluminant grey circles (condition ii)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circular array with clockwise shift (condition iii)
Number of subjects: 0
Study: 2497490

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30788839

Group type: EXPERIMENTAL
Intervention: New-design audit and feedback (NA&F)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Printed educational material (PEM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routinely conducted audit and feedback (RA&F)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall prescribing of injectables
Number of subjects: 0
Study: 27899497

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 351

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 351
Study: 26302276

Group type: EXPERIMENTAL
Intervention: Education group
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control (brochure) group
Number of subjects: 300
Study: 23263559

Group type: EXPERIMENTAL
Intervention: Tacrolimus once-daily regimen
Number of subjects: 219

Group type: COMPARATOR
Intervention: Tacrolimus twice-daily regimen
Number of subjects: 219
Study: 21719530

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin embedded in a phosphorylcholine matrix (XPC group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Phosphorylcholine coating (PC group)
Number of subjects: 30
Study: 19127975

Group type: EXPERIMENTAL
Intervention: Free primary health care (prepayment scheme allowing free primary care including drugs)
Number of subjects: 2592

Group type: COMPARATOR
Intervention: User fees for health care (control group)
Number of subjects: 2592

Group type: EXPERIMENTAL
Intervention: Free primary health care (prepayment scheme)
Number of subjects: 2592
Study: 16639496

Group type: EXPERIMENTAL
Intervention: MR fluoroscopy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Manometry
Number of subjects: 28

Group type: COMPARATOR
Intervention: Barium contrast radiography
Number of subjects: 28
Study: 14752429

Group type: EXPERIMENTAL
Intervention: Total arterial revascularization (left internal thoracic artery on left anterior descending coronary artery plus radial artery)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard coronary artery bypass graft surgery (left internal thoracic artery on left anterior descending coronary artery plus saphenous veins)
Number of subjects: 160
Study: 11423055

Group type: EXPERIMENTAL
Intervention: Nesiritide (0.015 microg/kg/min)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Dobutamine (standard therapy)
Number of subjects: 305
Study: 9290362

Group type: EXPERIMENTAL
Intervention: Hyaluronan ophthalmic solution (0.1% hyaluronic acid), instilled five times a day to the right eye
Number of subjects: 11

Group type: COMPARATOR
Intervention: Artificial tear solutions (control group)
Number of subjects: 11
Study: 7975402

Group type: EXPERIMENTAL
Intervention: Anti-arteriosclerosis diet containing 20 g of ichthyenic oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SPI-containing diet
Number of subjects: 0
Study: 2890806

Group type: EXPERIMENTAL
Intervention: DL‐dihydroxyphenylserine 600 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 29489078

Group type: EXPERIMENTAL
Intervention: Methylphenidate (low, medium, high dosages)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 28124381

Group type: EXPERIMENTAL
Intervention: Soccer training (n=19; 128±29 one‐h sessions over one year)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Soccer training (n=19)
Number of subjects: 31
Study: 26150502

Group type: EXPERIMENTAL
Intervention: Increased hand hygiene intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased hand hygiene and face masks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laboratory confirmation of infections by RT‐PCR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Children
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mean generation time
Number of subjects: 0
Study: 23954343

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 24674

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24674
Study: 21964714

Group type: EXPERIMENTAL
Intervention: Fast track (FT) nasogastric decompression
Number of subjects: 141

Group type: COMPARATOR
Intervention: Traditional nasogastric decompression
Number of subjects: 141
Study: 18562367

Group type: EXPERIMENTAL
Intervention: TM Indiana Tome (Biomet, Warsaw, Indiana, USA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard limited palmar incision
Number of subjects: 200
Study: 16644430

Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine (LDD) stress echocardiography (peak infusion 10 microg/kg/min)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine (LDD) stress echocardiography
Number of subjects: 66
Study: 12676043

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for migraine/headaches
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for nausea/vomiting
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall reporting of clinical details in RCTs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quality of randomization
Number of subjects: 30
Study: 10653203

Group type: EXPERIMENTAL
Intervention: Abecarnil (12 mg, three times daily)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Diazepam (22 mg, three times daily)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 9015985

Group type: EXPERIMENTAL
Intervention: Nimbus II mattress
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pegasus Airwave mattress
Number of subjects: 0
Study: 2000798

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (cycle ergometry, 3 times per week for 1 hour)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Nonaerobic yoga (2 times per week for 1 hour)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Waiting list nonexercise control group
Number of subjects: 101
Study: 6134827

Group type: EXPERIMENTAL
Intervention: Androgen (testoral)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Minor tranquillizer
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Androgens
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Weekly sessions
Number of subjects: 48

Group type: COMPARATOR
Intervention: Monthly sessions
Number of subjects: 48
Study: 30157015

Group type: EXPERIMENTAL
Intervention: Community Reintegration for Socially Isolated Patients (CRISP) program, 12-week educational socialization program
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Community Reintegration for Socially Isolated Patients (CRISP) program
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 27112723

Group type: EXPERIMENTAL
Intervention: Immediate loading of 2 unsplinted implants
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unloaded implants (control)
Number of subjects: 18
Study: 25504721

Group type: EXPERIMENTAL
Intervention: Contact with gay canvassers
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: Contact with straight canvassers
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: Follow-up experiment
Number of subjects: 972
Study: 23240867

Group type: EXPERIMENTAL
Intervention: Perceptually rich objects (high perceptual richness, low established knowledge)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Perceptually rich objects (high perceptual richness, high established knowledge)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Perceptually low objects (low perceptual richness, low established knowledge)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Perceptually low objects (low perceptual richness, high established knowledge)
Number of subjects: 133
Study: 20522536

Group type: EXPERIMENTAL
Intervention: FG‐3019 (3 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: FG‐3019 (10 mg/kg)
Number of subjects: 24
Study: 17616845

Group type: EXPERIMENTAL
Intervention: Internet-supervised patient self-management
Number of subjects: 60

Group type: COMPARATOR
Intervention: Anticoagulation clinic (control period)
Number of subjects: 60
Study: 16906395

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract (EGb) 360 mg/day plus haloperidol 0.25 mg/kg/day
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo plus haloperidol 0.25 mg/kg/day
Number of subjects: 109
Study: 12721253

Group type: EXPERIMENTAL
Intervention: Amifostine (740 mg/m2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10719311

Group type: EXPERIMENTAL
Intervention: DBPCFC with egg (first dose 500 mg or less)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with milk (first dose 500 mg or less)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with soy (first dose 500 mg or less)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with wheat (first dose 500 mg or less)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with peanut (first dose 500 mg or less)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with fish (first dose 500 mg or less)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with milk (first dose 250 mg)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with egg (first dose 250 mg)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with milk (first dose 100 mg)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC with egg (first dose 100 mg)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC (final dose or open challenge) with egg
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC (final dose or open challenge) with milk
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC (final dose or open challenge) with soy
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC (final dose or open challenge) with wheat
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC (final dose or open challenge) with peanut
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: DBPCFC (final dose or open challenge) with fish
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: First dose reactions severity
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Correlation of PST and RAST with dose and severity
Number of subjects: 196
Study: 8658221

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PSK or OK‐432 (biological response modifiers) added to chemotherapy
Number of subjects: 0
Study: 1329251

Group type: COMPARATOR
Intervention: Unfractionated heparin (UF) 15,000 units, three subcutaneous injections (Group 1)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Parnaparin 6,400 units, single injection (Group 2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Parnaparin 12,800 units, single injection (Group 3)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Parnaparin (both dosages)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Parnaparin
Number of subjects: 50
Study: 3862230

Group type: EXPERIMENTAL
Intervention: Sugar free chewing gum containing 0.25 mg fluoride
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sugar free chewing gum without fluoride (placebo)
Number of subjects: 20
Study: 31415087

Group type: EXPERIMENTAL
Intervention: 90 mg of fezolinetant twice daily for 12 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 28843079

Group type: EXPERIMENTAL
Intervention: PTSD symptom reduction
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Reduction in hopelessness
Number of subjects: 159